Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6972 | 1345 | 57.0 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
14 | 37098 | ALZHEIMERS DISEASE//AMYLOID PRECURSOR PROTEIN//BETA AMYLOID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CLIOQUINOL | Author keyword | 30 | 44% | 4% | 51 |
2 | OXIDAT BIOL | Address | 18 | 47% | 2% | 28 |
3 | OXIDAT BIOLGENET AGING UNIT | Address | 17 | 79% | 1% | 11 |
4 | OXIDAT DISORDERS | Address | 11 | 67% | 1% | 10 |
5 | GENET AGING UNIT | Address | 8 | 20% | 3% | 38 |
6 | GENET AGING UNIT OXIDAT BIOL | Address | 8 | 100% | 0% | 5 |
7 | COGNIT SCI TECHNOL CNR | Address | 6 | 80% | 0% | 4 |
8 | METAL PROTEIN ATTENUATING COMPOUNDS | Author keyword | 6 | 100% | 0% | 4 |
9 | R P ORT FAMILY MED HAIFA | Address | 6 | 100% | 0% | 4 |
10 | PBT2 | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLIOQUINOL | 30 | 44% | 4% | 51 | Search CLIOQUINOL | Search CLIOQUINOL |
2 | METAL PROTEIN ATTENUATING COMPOUNDS | 6 | 100% | 0% | 4 | Search METAL+PROTEIN+ATTENUATING+COMPOUNDS | Search METAL+PROTEIN+ATTENUATING+COMPOUNDS |
3 | PBT2 | 4 | 67% | 0% | 4 | Search PBT2 | Search PBT2 |
4 | NORMAL HUMAN BRAIN | 3 | 57% | 0% | 4 | Search NORMAL+HUMAN+BRAIN | Search NORMAL+HUMAN+BRAIN |
5 | AMYLOID BETA PEPTIDES | 3 | 12% | 2% | 25 | Search AMYLOID+BETA+PEPTIDES | Search AMYLOID+BETA+PEPTIDES |
6 | COPPER BINDING | 2 | 18% | 1% | 12 | Search COPPER+BINDING | Search COPPER+BINDING |
7 | DIMERCAPTOPROPANOL | 2 | 67% | 0% | 2 | Search DIMERCAPTOPROPANOL | Search DIMERCAPTOPROPANOL |
8 | MERCURY 203 | 2 | 67% | 0% | 2 | Search MERCURY+203 | Search MERCURY+203 |
9 | METAL DYSREGULATION | 2 | 67% | 0% | 2 | Search METAL+DYSREGULATION | Search METAL+DYSREGULATION |
10 | REGULATORY HEME | 2 | 67% | 0% | 2 | Search REGULATORY+HEME | Search REGULATORY+HEME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALZHEIMER A BETA | 81 | 57% | 7% | 96 |
2 | TARGETING A BETA | 46 | 61% | 4% | 49 |
3 | CLIOQUINOL | 36 | 50% | 4% | 52 |
4 | DIPHENYLPROPYNONE DERIVATIVES | 20 | 100% | 1% | 9 |
5 | SERUM FREE COPPER | 20 | 100% | 1% | 9 |
6 | FIBRILLAR FORMS | 14 | 100% | 1% | 7 |
7 | COPPER BINDING | 12 | 15% | 5% | 72 |
8 | REDOX ACTIVE IRON | 12 | 39% | 2% | 24 |
9 | 3 HISTIDINE RESIDUES | 11 | 100% | 0% | 6 |
10 | CUII POTENTIATION | 11 | 100% | 0% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Metal Theory of Alzheimer's Disease | 2013 | 40 | 27 | 78% |
Metal Ions and Intrinsically Disordered Proteins and Peptides: From Cu/Zn Amyloid-beta to General Principles | 2014 | 15 | 44 | 73% |
Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity | 2011 | 79 | 127 | 82% |
Metal-associated amyloid-beta species in Alzheimer's disease | 2012 | 56 | 40 | 73% |
Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide | 2009 | 171 | 128 | 65% |
Towards a Unified Vision of Copper Involvement in Alzheimer's Disease: A Review Connecting Basic, Experimental, and Clinical Research | 2015 | 2 | 64 | 63% |
Biological metals and metal-targeting compounds in major neurodegenerative diseases | 2014 | 18 | 322 | 45% |
Metals in Alzheimer's and Parkinson's diseases | 2008 | 276 | 71 | 45% |
Therapeutics for Alzheimer's disease based on the Metal Hypothesis | 2008 | 190 | 118 | 59% |
Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders | 2012 | 50 | 41 | 66% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OXIDAT BIOL | 18 | 47% | 2.1% | 28 |
2 | OXIDAT BIOLGENET AGING UNIT | 17 | 79% | 0.8% | 11 |
3 | OXIDAT DISORDERS | 11 | 67% | 0.7% | 10 |
4 | GENET AGING UNIT | 8 | 20% | 2.8% | 38 |
5 | GENET AGING UNIT OXIDAT BIOL | 8 | 100% | 0.4% | 5 |
6 | COGNIT SCI TECHNOL CNR | 6 | 80% | 0.3% | 4 |
7 | R P ORT FAMILY MED HAIFA | 6 | 100% | 0.3% | 4 |
8 | MENTAL HLTH VICTORIA | 4 | 26% | 1.0% | 14 |
9 | ICCOM CHEM ORGANOMETALL CPDS | 4 | 75% | 0.2% | 3 |
10 | ORGAN CHEM NEUROBIOL | 4 | 75% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000148678 | MEMBRANE SCI//SANDERS BROWN AGING//REDOX PROTEOMICS |
2 | 0.0000133925 | METAL IMBALANCE//INDUCTION MAINTENANCE THERAPY//TPIRC |
3 | 0.0000126107 | SYNAPTIC ZINC//GLOBAL COESURUGA KU//TSQ |
4 | 0.0000120486 | IODOQUINOL//CHINOFORM//DIIODOQUIN |
5 | 0.0000105572 | AMYLOID FIBRIL//AMYLOID FIBRILS//AMYLOID |
6 | 0.0000085623 | MOL BASIS NEURODEGENERAT//AMYLOID TOXICITY//MOL BASIS NEURODEGENERAT CIMN |
7 | 0.0000083155 | 3 4 5 DIMETHYLTHIAZOL 2 YL 2 5 DIPHENYLTETRAZOLIUM BROMIDE//ANAL CHIM CLIN MICROBIOL DIAGNOST MOL//BETA AMYLOID FRAGMENTS |
8 | 0.0000063257 | SPECTRUM STRUCTURE CORRELATION//GHK//EVANS CHEM |
9 | 0.0000060879 | ABAD//ERAB//STUDY NEURODEGENERAT DIS |
10 | 0.0000060385 | BAPINEUZUMAB//INTRANEURONAL ABETA//SOLANEZUMAB |